A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas-Reference-Cited by-同舟云学术

A phase I trial of lenalidomide and radiotherapy in children with diffuse intrinsic pontine gliomas or high-grade gliomas

Published:2020-09 Issue:3 Volume:149 Page:437-445
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Hipp Sean J.^ORCID,Goldman Stewart,Kaushal Aradhana,Krauze Andra,Citrin Deborah,Glod John,Walker Kim,Shih Joanna H.,Sethumadhavan Hema,O’Neill Keith,Garvin James H.,Glade-Bender Julia,Karajannis Matthias A.,Atlas Mark P.,Odabas Arman,Rodgers Louis T.,Peer Cody J.,Savage Jason,Camphausen Kevin A.,Packer Roger J.,Figg W. Douglas,Warren Katherine E.

Funder

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11060-020-03627-0.pdf

Reference10 articles.

1. Paugh B, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax D, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison D, Grundy R, Baker S (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28:3061–3068

2. Fangusaro J, Warren K (2013) Unclear standard of care for pediatric high grade glioma patients. J Neurooncol 113:341–342

3. Sharma R, Steward W, Daines C, Knight R, O’Byrne K, Dalgleish A (2006) Toxicity profile of the immunomodulatory thalidomide analogue, lenalidomide: phase I clinical trial of three dosing schedules in patients with solid malignancies. Eur J Cancer 42:2318–2325